The supply of GLP-1 drugs for weight loss and diabetes treatment is expected to tighten this week with a federal deadline to ...

Compounding pharmacies were allowed to step in to fill supply gaps while name-brand products ... with the FDA regarding the manufacturing and supply” of Wegovy and Ozempic, and the company ...

(CNN) – The crackdown on off-brand weight loss and diabetes treatment drugs is about to take effect, meaning supplies for the treatments are likely to tighten. A federal deadline to halt sales of the ...

Starting in 2022, increased demand led to shortages of semaglutide injections sold by Novo Nordisk under the brand names Ozempic ... when the drug manufacturers’ “stated product availability ...